HCW Biologics Stock Scores Biggest Gain Since May As Cancer Drug Breakthrough Fuels Blockbuster Hopes
The biotech firm said its next-generation version of Keytruda showed stronger results in early studies and could eventually expand into both cancer and age-related disease treatments.